Home / France / Cellectis

Cellectis

No short position is open on this share today.

0.00% of the capital sold short

0 disclosing funds

136 disclosures on record

Evolution of the disclosed total

0%0.2%0.4%0.6%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

Over the whole history, the total peaked at 3.57% on February 22, 2016. The shaded band matches the twelve months of the first chart.

March 30, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Cellectis by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

136 disclosures on record for this share.
Date	Fund	% of capital	End of publication
February 26, 2016	Partner Fund Management, L.P.	1.13%	March 16, 2016
February 26, 2016	PFM Health Sciences, LP	1.13%	March 16, 2016
February 26, 2016	Oxford Asset Management LLP	0.48%	March 1, 2016
February 22, 2016	Millennium International Management LP	0.56%	May 31, 2016
February 16, 2016	Oxford Asset Management LLP	0.59%	March 1, 2016
February 3, 2016	Partner Fund Management, L.P.	1.21%	March 16, 2016
February 3, 2016	PFM Health Sciences, LP	1.21%	March 16, 2016
February 3, 2016	Oxford Asset Management LLP	0.60%	March 1, 2016
January 20, 2016	Oxford Asset Management LLP	0.50%	March 1, 2016
January 11, 2016	Partner Fund Management, L.P.	0.89%	March 16, 2016
January 11, 2016	PFM Health Sciences, LP	0.89%	March 16, 2016
December 17, 2015	Oxford Asset Management LLP	0.49%	December 21, 2015
December 15, 2015	Oxford Asset Management LLP	0.50%	December 21, 2015
December 9, 2015	Partner Fund Management, L.P.	0.77%	March 16, 2016
December 9, 2015	PFM Health Sciences, LP	0.77%	March 16, 2016
November 13, 2015	Partner Fund Management, L.P.	0.93%	March 16, 2016
November 13, 2015	PFM Health Sciences, LP	0.93%	March 16, 2016
November 12, 2015	Partner Fund Management, L.P.	0.74%	March 16, 2016
November 12, 2015	PFM Health Sciences, LP	0.74%	March 16, 2016
November 11, 2015	Partner Fund Management, L.P.	0.63%	March 16, 2016
November 11, 2015	PFM Health Sciences, LP	0.63%	March 16, 2016
November 10, 2015	POINT72 Asset Management, L.P.	0.43%	November 12, 2015
November 6, 2015	POINT72 Asset Management, L.P.	0.57%	November 12, 2015
November 4, 2015	Partner Fund Management, L.P.	0.54%	March 16, 2016
November 4, 2015	PFM Health Sciences, LP	0.54%	March 16, 2016
October 30, 2015	Partner Fund Management, L.P.	0.68%	March 16, 2016
October 30, 2015	PFM Health Sciences, LP	0.68%	March 16, 2016
October 15, 2015	Partner Fund Management, L.P.	0.79%	March 16, 2016
October 15, 2015	PFM Health Sciences, LP	0.79%	March 16, 2016
May 21, 2015	Millennium International Management LP	0.47%	May 25, 2015
April 29, 2015	Millennium International Management LP	0.61%	May 25, 2015
April 28, 2015	Millennium International Management LP	0.55%	May 25, 2015
April 1, 2015	Merrill Lynch Pierce, Fenner and Smith Incorporated	0.48%	April 3, 2015
April 1, 2015	Merrill Lynch, Pierce, Fenner & Smith Incorporated	0.48%	April 3, 2015
March 30, 2015	Merrill Lynch Pierce, Fenner and Smith Incorporated	1.11%	April 3, 2015
March 30, 2015	Merrill Lynch, Pierce, Fenner & Smith Incorporated	1.11%	April 3, 2015

Download 136 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in France

Ubisoft Entertainment 12.49% of the capital sold short
Valeo 11.40% of the capital sold short
Renault 9.16% of the capital sold short
Viridien 8.08% of the capital sold short
Teleperformance 7.58% of the capital sold short
FDJ United 6.19% of the capital sold short
Abivax 5.10% of the capital sold short
Elis 4.91% of the capital sold short
Alstom 4.57% of the capital sold short
Rémy Cointreau 4.46% of the capital sold short
Sopra Steria Group 3.92% of the capital sold short
Spie SA 3.75% of the capital sold short

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Cellectis, source AMF, data as at September 17, 2026, https://www.quivad.com/action/cellectis?page=3